Please assess the completion status of the following clinical trial:

Trial Title: Improving Medication Adherence in ADHD Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of ADHD; currently prescribed an FDA-approved medication for ADHD, history of medication nonadherence (taking less than 60% of prescribed doses); full scale Intelligence Quotient \>80, no current language delay and/or had no language delays before age 3.~Exclusion Criteria:~* active medical conditions that could be worsened by stimulants (seizures, arrhythmias, hypertension) unless patient has clearance from primary specialist taking care of existing condition, pregnancy, Bipolar Disorder, schizophrenia, and/or other psychotic disorders, and diagnosis of current substance abuse or dependence (except nicotine), current psychotropic medication for conditions other than ADHD.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Medication as usual (Type: ACTIVE_COMPARATOR): Medication as typically prescribed by physician.
- Medication as usual + STAR (Type: ACTIVE_COMPARATOR): Medication as typically prescribed with the addition of the psychosocial intervention to improve medication adherence

Based on this trial design, predict the completion outcome and termination type (if applicable).